Abstract:
Objective To establish a reasonable evaluation system for ulinastatin to provide a reference for evaluating the rationality of ulinastatin application.
Methods The detailed evaluation rules for the rationality of ulinastatin application were formulated. The weights of each evaluation index was calculated through the Analytic Hierarchy Process (AHP), and the rationality of drug use in Bozhou Hospital Affiliated to Anhui Medical University from February 2023 to October 2024 was analyzed using the distance between superior and inferior solutions (TOPSIS).
Results An evaluation system was established, which included 4 first-level indicators and 10 second-level indicators. Among the 199 patients, the proportions of completely reasonable medication, reasonable medication, basically reasonable medication and were 11.06% (22/199), 17.09% (34/199), 46.23% (92/199) and 25.63% (51/199), respectively.
Conclusions The application of ulinastatin in this hospital is basically reasonable, but there are still certain degrees of irrationality in terms of the indications for administration and the dosage and administration, which need to be further improved.